Our Gateway to Insightful Blogging Exploring Ideas, Sharing Knowledge, Inspiring Minds
Overview Nemluvio®, (nemolizumab) is a novel monoclonal antibody which was approved in August 2024 by the Food and Drug Administration of United States (FDA) to treat prurigo nodularis in adults. This approval is welcome news in the dermatology field and presents new hope for patients suffering from chronic inflammatory disorders …
Read More »Nemolizumab in the USA : Breakthrough in Targeted Therapy
